Pharmafile Logo

One-carbon Therapeutics

- PMLiVE

One-carbon Therapeutics appoints Stefan Larsson and Raj Shah to Board of Directors

Larsson is co-founder and Board Chair of the International Consortium for Health Outcomes Measurement

- PMLiVE

One-carbon Therapeutics collaborates with Tempus in cancer treatment

The treatment is currently being evaluated in a phase 1/2 multicentre clinical study

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links